Barrett Esophagus It is an illness of the mucous membrane of the esophagus that has been developed during numerous years of exposure to the stomach acid. The columnar cells that are more intestine-like gradually replace the normal squamous cells. It is more preferable that the impact of such cell transformation would result in the formation of esophageal cancer and therefore, the eruption of such type of cancer must be detected and traced.
The early Barrett Esophagus does not have any symptoms that can be associated with it. They are expressed in aberrant circumstances, exposed to intractable acid reflux:
Barrett Esophagus was created to counteract the persistent acid reflux on the basis of which the lining of the esophagus is destroyed. Key risk factors include:
In the case of the GastroDoxs, in Houston, with which we, as professionals, will train the Esophagus of Barrett in the nearest future and the existing technologies of the endoscopic study and the creation of the own treatment program and control is not an exception. We will make sure we meet you half way, be accommodative and expressive. Call the doctor now and be prepared to join the team that is good to work with at all time in Houston and a master of his esophagus.
We've successfully treated more than 4.3K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
The code applied to the medical records and billing code is ICD-10 K22.7 and code of Esophagus in Barrett.
Some of the patients would present themselves without symptoms in the initial stages. They are able not only to duplicate the chronic reflux of the acid, but they are also preceded by heartburn, burning in the chest, pain in swallowing, sour regurgitation of liquids, chronic cough, hoarseness, or unexplained weight loss.
The latter is a chronic exposure to intestinal acid which is instigated by GERD (gastroesophageal reflux disease). Other contributing factors include hiatal hernia, smoking, abdominal and waist obesity, and a family history of Barrett’s or esophageal cancer.
Yes, Barrett’s Esophagus exposes one to the risks of esophageal adenocarcinoma. Regular checkups and prevention of precancerous lesions at a younger age are recommended.
This means that in the esophagus, no dysplastic cells occur — denoted as Barrett’s without dysplasia — because the normal cells of the esophagus are distorted but not precancerous. It should still be monitored occasionally to detect any changes in the cells over time.
Treatment is directed towards lowering acid levels, eliminating abnormal cells, and preventing cancer. These may include proton pump inhibitors (PPIs), H2 blockers, endoscopic ablation or mucosal resection, and in some cases, fundoplication surgery.
A low-acid and low-fat diet is recommended. Focus on low-fat foods, vegetables, and whole grains, while avoiding citrus fruits, spicy foods, caffeine, alcohol, and other irritating foods.
Yes. H2 blockers and proton pump inhibitors (PPIs) reduce esophageal acid secretion, heal the mucosal lining, and minimize reflux symptoms.
Yes. A gastroenterologist provides specialized knowledge on Barrett’s Esophagus, enabling accurate diagnosis, effective treatment, and close monitoring to reduce cancer risk.
The average period for endoscopy has been suggested to be every 3–5 years in patients with Barrett’s Esophagus free of dysplasia. More frequent monitoring may be recommended if low- or high-grade dysplasia is detected.
